Registry-listed formulations

Rose Bengal · mesh:M0019269

Each study is counted once in the molecule profile. Registry products remain separate. Naming an ingredient does not establish that products are interchangeable or what participants received.

1 source entries across 1 studies. This list may not include all unresolved or historical entries.

  • Topical Rose Bengal, 0.005%Registry intervention

    Linked study entry; product equivalence not established

    View study and source

Success Metrics

Clinical Success Rate
100.0%

Based on 2 completed trials

Completion Rate
100%(2/2)
Active Trials
0(0%)
Results Posted
50%(1 trials)

Phase Distribution

Phase 2
1
33%
Phase 3
1
33%

Phase Distribution

0

Early Stage

1

Mid Stage

1

Late Stage

Phase Distribution2 total trials
Phase 2Efficacy & side effects
1(50.0%)
Phase 3Large-scale testing
1(50.0%)

Highest Phase Reached

Phase 3

Trial Status & Enrollment

Completion Rate

100.0%

2 of 2 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

0

trials recruiting

Total Trials

3

all time

Status Distribution
Completed(2)
Other(1)

Detailed Status

Completed2
unknown1

Development Timeline

Analytics

Development Status

Total Trials
3
Active
0
Success Rate
100.0%
Most Advanced
Phase 3

Trials by Phase

Phase 21 (50.0%)
Phase 31 (50.0%)

Trials by Status

unknown133%
completed267%

Recent Activity

0 active trials
Showing 3 of 3
unknownphase_3

Curcumin; Rose Bengal; Denture Stomatitis

NCT04837664
completed

Comparison or Rose Bengal and Toluidine Blue Staining for Lesion Detection Efficacy

NCT03031899
completedphase_2

A Phase 2 Study of Cellular and Immunologic Changes in the Skin of Subjects Receiving PH-10

NCT02322086

Clinical Trials (3)

Showing 3 of 3 trials
NCT04837664Phase 3

Curcumin; Rose Bengal; Denture Stomatitis

Unknown
NCT03031899

Comparison or Rose Bengal and Toluidine Blue Staining for Lesion Detection Efficacy

Completed
NCT02322086Phase 2

A Phase 2 Study of Cellular and Immunologic Changes in the Skin of Subjects Receiving PH-10

Completed

All 3 trials loaded

Drug Details

Intervention Type
Varies by study
Total Trials
3